Modulating effects of fumonisin B1 and ochratoxin A on leukocytes and messenger cytokines of the human immune system

International Immunopharmacology

Volumn 8, Issue 6, 2008, Pages 799-809

  Odhav, Bharti ^a   Adam, Jamila K ^a   Bhoola, Kanti D ^b  

^a DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cytokines; Fumonisin B1; Leukocytes; Mycotoxins; Ochratoxin A; Oesophageal and breast carcinomas

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CYTOKINE; FUMONISIN B1; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOTOXIN; OCHRATOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME BLOOD LEVEL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IC 50; IMMUNE SYSTEM; IMMUNOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEUTROPHIL; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CYTOKINES; ESOPHAGEAL NEOPLASMS; FEMALE; FUMONISINS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEUTROPHILS; OCHRATOXINS; RECEPTORS, CHEMOKINE; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42649114775     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.030     Document Type: Article

References (29)

1. Bacon C.W., and Nelson P.E. Fumonisin production in corn by toxigenic strains of F. moniliforme and F. proliferatum. J Food Prot 57 (1994) 514-521
2. Wang L.D., Yang H.H., Fan Z.M., Lu X.D., Wang J.K., Liu X.L., et al. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China. Cancer Detect Prev 29 (2005) 317-322
3. Creppy E.E., Chiarappa P., Baudrimont I., Borracci P., Moukha S., and Carratu M.R. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?. Toxicology 20 (2004) 115-123
4. Wafa E.W., Yahya R.S., Sobh M.A., Erakhy I., el-Baz M., el-Gayer H.A., et al. Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Hum Exp Toxicol 17 (1998) 124-129
5. Ehrlich V., Darroudi F., Uhl M., Steinkellner H., Gann M., Majer B.J., et al. Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem Toxicol 40 (2002) 1085-1090
6. Petzinger E., and Ziegler K. Ochratoxin A from a toxicological perspective. J Vet Pharmacol Ther 23 (2000) 91-98
7. Schlatter C., Studer-Rohr J., and Rasonyi T. Carcinogenecity and kinetic aspects of Ochratoxin A. Food Addit Contam 13 (1996) 43-44
8. Boyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1 g gravity field. Scand J Clin Lab Invest Suppl 97 (1968) 51-76
9. Freshney R.I. Effects of glucocorticoids on glioma cells in culture. Minireview on cancer research. Exp Cell Biol 52 (1984) 286-292
10. S. Naicker. Incidence and characteristics of Fusarium species from mycotic keratitis infection. M Tech Biotechnology Thesis 2001: M L Sultan Technikon, Durban, South Africa. 1.
11. B. Odhav. Pathogenesis of chancroid: Haemophilus ducreyi induced tissue damage. PhD Thesis. 1996: University of Natal, Durban, South Africa.
12. Martinova E.A., and Merrill A.H. Fumonisin B1 alters sphingolipid metabolism and immune function in BALB/c mice: Immunological responses to fumonisin Bl My copathologia vol. 130 (1995) 163-170
13. Martinova E.A., Solovev A.S., Rhenov A.V., Zabotina T.N., and Alesenfo A.V. Fumonisin B1 modulates sphingomyelin cycle product levels and the expression of CD3 receptors in immunocompetent organs. Biochemistry-Moscow 60 (1995) 461-465
14. Johnson V.J., He Q., Kim S.H., Kant A., and Sharma R.P. Increased susceptibility of renal epithelial cells to TNF alpha induced apoptosis following treatment with fumonisin B1. Chem Biol Interact 145 (2003) 297-309
15. Tolleson W.H., Dooley K.L., Sheldon W.G., Thurman T.J., Bucci T.J., and Howard P.C. The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. In: Jackson L.S., DeVries J.W., and Bullerman L.B. (Eds). Fumonisins in Foods (1996), Plenum Press, New York 239-349
16. Engelbrecht J.C., and Purchase I.F.H. Changes in morphology of cell cultures after treatment with aflatoxin and oxhratoxin. S Afr Med J 30 (1969) 524-527
17. Paul S., Regulier E., Poitevin Y., Hormann H., and Acres R.B. The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer. Cancer Immunol Immunother 51 (2002) 645-654
18. Suganuma M., Okabe S., Marino M.W., Sakai A., Sueoka E., and Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 95 (1999) 4516-4518
19. Dugyala R.R., Sharma R.P., Tsunoda M., and Riley R.T. Tumor necrosis factor-alpha as a contributor in fumonisin B1 toxicity. J Pharmacol Exp Ther 285 (1998) 317-324
20. Waller E.K., and Ernstoff M.S. Modulation of antitumor immune responses by hematopoietic cytokines. Cancer 97 (2003) 1797-1809
21. Wang E., Norred W.P., Bacon C.W., Riley R.T., and Merrill Jr. A.H. Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J Biol Chem 266 (1991) 144-186
22. Yoo H.S., Norred W.P., Wang E., Merrill A.H., and Riley R.T. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Phamcol 114 (1992) 9-15
23. Merrill A.H., Wang E., Gilchrist D.G., and Riley R.T. Fumonisins and othe inhibitors of de novo sphingolipid biosynthesis. Advances in lipid research vol. 26 (1993), Academic Press, New York 215-234
24. Schroeder J.J., Crane H.M., Xia J., Liotta D.C., and Merrill Jr. A.H. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. Amolecular mechanism for carcinogenesis associated with Fusarium moniliforme. J Biol Chem 269 (1994) 3475-3481
25. Harel R., and Futerman A.H. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J Biol Chem 268 (1993) 1476-1481
26. Riley R.T., Voss K.A., Yoo H.S., Gelderblom W.C.A., and Merrill Jr. A.H. Mechanisim of fumonisin toxicity and carcinogenesis. J. Food Prot 57 (1994) 528-535
27. Adler H.L., McCurdy M.A., Kattan M.W., Timme T.L., Scardino P.T., and Thompson T.C. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol 161 (1999) 182-187
28. Basolo F., Fiore L., Pollina L., Fontanini G., Conaldi P.G., and Toniolo A. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies. Clin Cancer Res 4 (1998) 381-387
29. Dinarello C.A. Multiple biological properties of recombinant human interleukin 1 (beta). Immunobiology 172 (1986) 301-315